Valneva SE (VALN) Retained Earnings (2019 - 2026)

Valneva SE (VALN) posted quarterly Retained Earnings of $96.7 million for Q1 2026, up 11.2% year-on-year from $87.0 million in Q1 2025, and up 2.01% on a QoQ basis from $94.8 million in Q4 2025.

Valneva SE (VALN) Retained Earnings (2019 - 2026) Analysis & Trends

Valneva SE (VALN) has reported Retained Earnings for 8 consecutive years, with $96.7 million the latest figure, recorded in Q1 2026.

  • Quarterly Retained Earnings rose 11.2% year-over-year to $96.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $96.7 million (up 11.2% YoY) and the FY2025 annual result came in at $94.8 million, up 115.1% from the prior year.
  • Retained Earnings advanced to $96.7 million in Q1 2026 per VALN's latest filing, from $94.8 million in the prior quarter.
  • Over the last five years, Retained Earnings for VALN reached as high as $96.7 million in Q1 2026 and fell as low as -$627.8 million in Q4 2024.
  • A 5-year average of $34.9 million and a median of $74.1 million in 2023 frame the typical range for Retained Earnings.
  • Annual changes were most pronounced in 2022 — Retained Earnings surged 123.66% — and 2024, when it sank 947.59%.
  • Year by year, Retained Earnings stood at $62.9 million in 2022, then grew by 17.8% to $74.1 million in 2023, then slumped by 947.59% to -$627.8 million in 2024, then surged by 115.1% to $94.8 million in 2025, then increased by 2.01% to $96.7 million in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods registered $96.7 million, $94.8 million, and $92.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -527.87 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -27.89 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 12.91 Bn
4 NuCana 279.75 Bn 279.75 Bn - 115.82 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 11.90 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -622,000.00
10 Valneva SE 803.90 Mn 680.66 Mn 5.38 Mn 96.72 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 96.72 Mn
Dec 31, 2025 94.81 Mn
Sep 30, 2025 92.61 Mn
Jun 30, 2025 90.04 Mn
Mar 31, 2025 86.98 Mn
Dec 31, 2024 -627.79 Mn
Sep 30, 2024 82.42 Mn
Jun 30, 2024 78.68 Mn
Mar 31, 2024 76.43 Mn
Dec 31, 2023 74.07 Mn
Sep 30, 2023 70.79 Mn
Jun 30, 2023 69.66 Mn
Mar 31, 2023 66.42 Mn
Dec 31, 2022 62.87 Mn
Sep 30, 2022 58.94 Mn
Jun 30, 2022 59.72 Mn
Mar 31, 2022 59.69 Mn
Dec 31, 2021 -265.77 Mn
Jun 30, 2021 60.70 Mn
Dec 31, 2020 60.11 Mn